These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7506658)

  • 1. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats.
    Bisaga A; Krzascik P; Jankowska E; Palejko W; Kostowski W; Danysz W
    Eur J Pharmacol; 1993 Oct; 242(3):213-20. PubMed ID: 7506658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations.
    Willmore CB; Bespalov AY; Beardsley PM
    Neurobiol Learn Mem; 2002 Sep; 78(2):347-64. PubMed ID: 12431422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
    Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
    Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effects of centrally injected kainate and N-methyl-D-aspartate on gastric acid secretion in anesthetized rats.
    Tsuchiya S; Horie S; Yano S; Watanabe K
    Brain Res; 2001 Sep; 914(1-2):115-22. PubMed ID: 11578604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycine site of the NMDA receptor contributes to neurokinin1 receptor agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons.
    Heppenstall PA; Fleetwood-Walker SM
    Brain Res; 1997 Jan; 744(2):235-45. PubMed ID: 9027383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S; Cebers G; Kalda A
    Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.
    Zajaczkowski W; Frankiewicz T; Parsons CG; Danysz W
    Neuropharmacology; 1997 Jul; 36(7):961-71. PubMed ID: 9257940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo.
    Obrenovitch TP; Urenjak J; Zilkha E
    Br J Pharmacol; 1994 Dec; 113(4):1295-302. PubMed ID: 7534184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones.
    Thomas NK; Clayton P; Jane DE
    Eur J Pharmacol; 1997 Nov; 338(2):111-6. PubMed ID: 9455991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
    Fink K; Schultheiss R; Göthert M
    Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine.
    Nishiyama T; Yaksh TL; Weber E
    Anesthesiology; 1998 Sep; 89(3):715-22. PubMed ID: 9743410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.